The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
Open accessAbstract
Recent evidence suggests that there is etiologic heterogeneity among the various subtypes of lymphoid neoplasms. However, epidemiologic analyses by disease subtype have proven challenging due to the numerous clinical and pathologic schemes used to classify lymphomas and lymphoid leukemias over the last several decades. On behalf of the International Lymphoma Epidemiology Consortium (InterLymph) Pathology Working Group, we present a proposed nested classification of lymphoid neoplasms to facilitate the analysis of lymphoid neoplasm subtypes in epidemiologic research. The proposed classification is based on the World Health Organization classification of lymphoid neoplasms and the International Classification of Diseases–Oncology, Third Edition (ICD-O-3). We also provide a translation into the proposed classification from previous classifications, including the Working Formulation, Revised European-American Lymphoma (REAL) classification, and ICD-O-2. We recommend that epidemiologic studies include analyses by lymphoma subtype to the most detailed extent allowable by sample size. The standardization of groupings for epidemiologic research of lymphoma subtypes is essential for comparing subtype-specific reports in the literature, harmonizing cases within a single study diagnosed using different systems, as well as combining data from multiple studies for the purpose of pooled analysis or meta-analysis, and will probably prove to be critical for elucidating etiologies of the various lymphoid neoplasms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“North American registries define multiple primary cancers under the rules of the Surveillance Epidemiology and End Results (SEER) programme.22 Those rules accept more cancers as new primary cancers than the rules of the International Association of Cancer Registries (IACR),23 which are used by most cancer registries in other continents.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citationWorld Health Organization Classification of Tumours
Fletcher, C., van den Berg, A., & Molenaar, I. (2002) · Cited by 7,079
Harris, N. L., Jaffe, E., Stein, H., Pm, B., Jk, C., Cleary, M. L., Delsol, G., Peeters, C., Falini, B., & Gatter, K. C. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,312
Bennett, J. M., Catovsky, D., Mt, D., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03563.x · Cited by 5,595
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,614
Rosenwald, A., Wright, G. W., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Müller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,832
Self-citationInternational Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,810
Cancer incidence, mortality and prevalence worldwide
Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796
The Non-Hodgkin's Lymphoma Pathologic Classification Project (1982) · Cancer · doi:10.1002/1097-0142(19820515)49:10 · Cited by 3,051
Research works printed but not linked: 4
- Percy, 2001, Conversion of neoplasms by topography and morphology from the International Classification of Diseases for Oncology, second edition, to International Classification of Diseases for Oncology, third edition.
- Van Holten, 1992, Conversion of neoplasms by topography and morphology from the International Classification of Diseases for Oncology (ICD-O; first edition and field trials) to International Classification of Diseases for Oncology, second edition (ICD-O-2).
- Rothman, 1998, Modern Epidemiology
- Chiu, 2005, Association of pesticides, smoking, and familial cancer with risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma., Proc Am Assoc Cancer Res, 46, 1307
Cited by
Sorted by citations
Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Sant, M., Allemani, C., Ţereanu, C., Angelis, R. D., Capocaccia, R., Visser, O. J., Marcos‐Gragera, R., Maynadié, M., Simonetti, A., Lutz, J.-M., et al. (2010) · Blood · doi:10.1182/blood-2010-05-282632 · Cited by 977
Self-citationCutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases
Bradford, P. T., Devesa, S. S., Anderson, W. F., & Toro, J. R. (2009) · Blood · doi:10.1182/blood-2008-10-184168 · Cited by 707
Smedby, K. E. E., Vajdic, C. M., Falster, M. O., Engels, E. A., Martı́nez-Maza, O., Turner, J., Hjalgrim, H., Vineis, P., Costantini, A. S., Bracci, P. M., et al. (2008) · Blood · doi:10.1182/blood-2007-10-119974 · Cited by 622
“‡Includes patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), prolymphocytic leukemia (PLL), and mantle cell lymphoma (MCL) (25).”
BackgroundInfluentialSelf-citationCancer incidence and mortality in France over the period 1980–2005
Belot, A., Grosclaude, P., Bossard, N., Jougla, É., Benhamou, E., Delafosse, P., Guizard, A., Molinié, F., Danzon, A., Bara, S., et al. (2008) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/j.respe.2008.03.117 · Cited by 539
Self-citation
Metadata
- Authors
- Morton, L. M., Turner, J. J., Cerhan, J. R., Linet, M. S., Treseler, P. A., Clarke, C. A., Jack, A., Cozen, W., Maynadié, M., Spinelli, J. J., Costantini, A. S., Rüdiger, T., Scarpa, A., Zheng, T., & Weisenburger, D. D.
- Affiliations
- National Institutes of Health (US)
- St Vincent's Hospital Sydney (AU)
- Mayo Clinic (US)
- University of California, San Francisco (US)
- Cancer Prevention Institute of California (US)
- National Health Service (GB)
- University of Southern California (US)
- CHU Dijon Bourgogne (FR)
- BC Cancer Agency (CA)
- Occupational and Environmental Epidemiology Unit, Center for Study and Prevention of Cancer, Scientific Institute of Tuscany, Florence, Italy;
- University of Würzburg (DE)
- University of Verona (IT)
- Yale University (US)
- University of Nebraska Medical Center (US)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2007-07-15
- Volume
- 110
- Issue
- 2
- Pages
- 695-708
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC1924473
- OpenAlex
- W2061918976
- Cited by
- 387
- References
- 58
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 17 · 2022: 14 · 2021: 16 · 2020: 14 · 2019: 14 · 2018: 14 · 2017: 15 · 2016: 23 · 2015: 30 · 2014: 45 · 2013: 28 · 2012: 34
- FWCI
- 20.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (P50CA97274, R01CA092153, R01CA062006, N01-CN-35136, CA 62006-05, R01CA92153, P50CA097274)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
- Keywords
- lymphoid malignancies, lymphoma subtypes, classification standardization, lymphoid leukemia, ICD-O-3, WHO classification of lymphoid neoplasms, REAL classification, Working Formulation, lymphoma etiology
- MeSH terms
- Europe, Hodgkin Disease, Humans, Lymphoma, Lymphoma, Non-Hodgkin, North America, Reproducibility of Results
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
